Literature DB >> 26043260

Correction: Overexpression of periostin in stroma positively associated with aggressive prostate cancer.

Yuan Tian, Caitlin H Choi, Qing Kay Li, Farah B Rahmatpanah, Xin Chen, Sara Ruth Kim, Robert Veltri, David Chia, Zhen Zhang, Dan Mercola, Hui Zhang.   

Abstract

Entities:  

Year:  2015        PMID: 26043260      PMCID: PMC4456420          DOI: 10.1371/journal.pone.0130333

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
There are errors in the Funding section. The correct funding information is as follows: This work was supported by National Institutes of Health, National Cancer Institute, the Early Detection Research Network (EDRN, U01CA152813) to HZ, the Prostate Cancer Biorepository Network, Department of Defense Grant Number W81XWH-10-2-0056, and Early Detection Research Network NCI CA86366 to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  1 in total

1.  Overexpression of periostin in stroma positively associated with aggressive prostate cancer.

Authors:  Yuan Tian; Caitlin H Choi; Qing Kay Li; Farah B Rahmatpanah; Xin Chen; Sara Ruth Kim; Robert Veltri; David Chia; Zhen Zhang; Dan Mercola; Hui Zhang
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

  1 in total
  2 in total

Review 1.  Periostin: biology and function in cancer.

Authors:  Shima Dorafshan; Mahdieh Razmi; Sadegh Safaei; Erica Gentilin; Zahra Madjd; Roya Ghods
Journal:  Cancer Cell Int       Date:  2022-10-12       Impact factor: 6.429

2.  Spatial Profiling of the Prostate Cancer Tumor Microenvironment Reveals Multiple Differences in Gene Expression and Correlation with Recurrence Risk.

Authors:  Vinay Kumar; Pavneet Randhawa; Robert Bilodeau; Dan Mercola; Michael McClelland; Anshu Agrawal; James Nguyen; Patricia Castro; Michael M Ittmann; Farah Rahmatpanah
Journal:  Cancers (Basel)       Date:  2022-10-08       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.